相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Economic Evaluations with Agent-Based Modelling: An Introduction
Jagpreet Chhatwal et al.
PHARMACOECONOMICS (2015)
Response to ''The Life Table Method of Half-Cycle Correction: Getting It Right''
David M. J. Naimark et al.
MEDICAL DECISION MAKING (2014)
The Life Table Method of Half Cycle Correction: Getting It Right
Jan J. Barendregt
MEDICAL DECISION MAKING (2014)
When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES
Jonathan Karnon et al.
PHARMACOECONOMICS (2014)
Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses
A. T. Newall et al.
VACCINE (2014)
Multicohort Models in Cost-Effectiveness Analysis: Why Aggregating Estimates over Multiple Cohorts Can Hide Useful Information
James F. O'Mahony et al.
MEDICAL DECISION MAKING (2013)
A Mathematical Approach for Evaluating Markov Models in Continuous Time without Discrete-Event Simulation
Joost van Rosmalen et al.
MEDICAL DECISION MAKING (2013)
The Half-Cycle Correction Revisited: Redemption of a Kludge
David M. J. Naimark et al.
MEDICAL DECISION MAKING (2013)
Survival Analysis for Economic Evaluations Alongside Clinical Trials-Extrapolation with Patient-Level Data: Inconsistencies, Limitations, and a Practical Guide
Nicholas R. Latimer
MEDICAL DECISION MAKING (2013)
Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?
Christopher McCabe et al.
PHARMACOECONOMICS (2013)
Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability
Anthony T. Newall et al.
PHARMACOECONOMICS (2013)
Budget allocation and the revealed social rate of time preference for health
Mike Paulden et al.
HEALTH ECONOMICS (2012)
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
Mark Roberts et al.
MEDICAL DECISION MAKING (2012)
Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
Marta O. Soares et al.
PHARMACOECONOMICS (2012)
Population- versus Cohort-Based Modelling Approaches
Olivier Ethgen et al.
PHARMACOECONOMICS (2012)
On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches
Tjalke A. Westra et al.
VALUE IN HEALTH (2012)
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Uwe Siebert et al.
VALUE IN HEALTH (2012)
Categorization of methods used in cost-effectiveness analyses of vaccination programs based on outcomes from dynamic transmission models
Josephine Mauskopf et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
DISCOUNTING AND DECISION MAKING IN THE ECONOMIC EVALUATION OF HEALTH-CARE TECHNOLOGIES
Karl Claxton et al.
HEALTH ECONOMICS (2011)
Practical Implications of Differential Discounting in Cost-Effectiveness Analyses with Varying Numbers of Cohorts
James F. O'Mahony et al.
VALUE IN HEALTH (2011)
Whose Costs and Benefits? Why Economic Evaluations Should Simulate Both Prevalent and All Future Incident Patient Cohorts
Martin Hoyle et al.
MEDICAL DECISION MAKING (2010)
Modelling the effect of conjugate vaccines in pneumococcal disease: Cohort or population models?
Baudouin Standaert et al.
VACCINE (2010)
Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland
Rianne de Gelder et al.
EUROPEAN JOURNAL OF CANCER (2009)
The Half-Cycle Correction: Banish Rather Than Explain It
Jan J. Barendregt
MEDICAL DECISION MAKING (2009)
Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine A Systematic Review
Fawziah Marra et al.
PHARMACOECONOMICS (2009)
How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands
Veerle M. H. Coupe et al.
VACCINE (2009)
The half-cycle correction explained: Two alternative pedagogical approaches
David M. J. Naimark et al.
MEDICAL DECISION MAKING (2008)
The half-life of truth: What are appropriate time horizons for research decisions?
Zoe Philips et al.
MEDICAL DECISION MAKING (2008)
Future drug prices and cost-effectiveness analyses
Martin Hoyle
PHARMACOECONOMICS (2008)
Time and expected value of sample information wait for no patient
Simon Eckermann et al.
VALUE IN HEALTH (2008)
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Mark Jit et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
A critique and impact analysis of decision modeling assumptions
Jonathan Karnon et al.
MEDICAL DECISION MAKING (2007)
Choice of modelling technique for evaluating health care interventions
K. Cooper et al.
JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY (2007)
Use of modeling to evaluate the cost-effectiveness of cancer screening programs
Amy B. Knudsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rates and probabilities in economic modelling - Transformation, translation and appropriate application
Rachael L. Fleurence et al.
PHARMACOECONOMICS (2007)
Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling
Sue J. Goldie et al.
VACCINE (2006)
Retrospective cost-effectiveness analysis of screening mammography
Natasha K. Stout et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Estimation of Markov chain transition probabilities and rates from fully and partially observed data: Uncertainty propagation, evidence synthesis, and model calibration
NJ Welton et al.
MEDICAL DECISION MAKING (2005)
Impact of generic drug entry on cost-effectiveness analysis
YCT Shih et al.
MEDICAL DECISION MAKING (2005)
The cost-effectiveness of screening programs using single and multiple birth cohort simulations: A comparison using a Model of cervical cancer
S Dewilde et al.
MEDICAL DECISION MAKING (2004)
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation
J Karnon
HEALTH ECONOMICS (2003)
Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR task force on good research practices-modeling studies
MC Weinstein et al.
VALUE IN HEALTH (2003)
Economic evaluation of vaccination programs: The impact of herd-immunity
M Brisson et al.
MEDICAL DECISION MAKING (2003)
Discounting for health effects in cost-benefit and cost-effectiveness analysis
H Gravelle et al.
HEALTH ECONOMICS (2001)
分享论文
